Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

100.04
Delayed Data
As of May 27
 +0.61 / +0.61%
Today’s Change
62.53
Today|||52-Week Range
112.00
+26.66%
Year-to-Date
New Strong Buy Stocks for May 27th
May 27 / Zacks.com - Paid Partner Content
S&P 500 to Celebrate One Year of New High: Top ETFs & Stocks
May 20 / Zacks.com - Paid Partner Content
2 Momentum Health Care Stocks That Will Continue to Outpace the Industry
May 25 / TheStreet.com - Paid Partner Content
Baxter (BAX) Raised to Strong Buy on Estimate Revisions
May 20 / Zacks.com - Paid Partner Content
Edwards Lifesciences: Q1 Strong, TAVR Prospects Bright
May 25 / Zacks.com - Paid Partner Content
Quality Systems (QSII) Q4 Earnings Disappoint, Stock Falls
May 20 / Zacks.com - Paid Partner Content
Edwards Lifesciences Has a Faulty 'Ticker'
May 24 / TheStreet.com - Paid Partner Content
Masimo (MASI) Scales a 52-Week High on Strong Q1 Results
May 19 / Zacks.com - Paid Partner Content
Edwards Lifesciences (EW) Stock Price Target Raised at Canaccord
May 23 / TheStreet.com - Paid Partner Content
Strong Q4 for PetMed (PETS), New Order & Reorder Sales Gain
May 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close99.43
Today’s open99.94
Day’s range98.97 - 100.60
Volume1,675,145
Average volume (3 months)1,976,039
Market cap$21.5B
Dividend yield--
Data as of 4:01pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-39.84%
Earnings growth (this year)+20.81%
Earnings growth (next 5 years)+17.15%
Revenue growth (last year)+7.35%
P/E ratio42.7
Price/Sales6.98
Price/Book8.73

Competitors

 Today’s
change
Today’s
% change
ZBHZimmer Biomet Holdin...+0.58+0.47%
BCRC R Bard Inc-0.58-0.26%
BSXBoston Scientific Co...+0.02+0.09%
BDXBecton Dickinson and...-0.20-0.12%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.70
Annual revenue (last year)$2.5B
Annual profit (last year)$494.9M
Net profit margin19.85%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts

Partner Offers

Search for Jobs